NASDAQ · ZYBT
Zhengye Biotechnology Holding Limited
Healthcare · Drug Manufacturers - Specialty & Generic
$1.38
Down-$0.04 (-2.82%)
Updated Sep 16, 2026, 11:08 AM
SID Score
4.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 94.78M
- P/E ratio
- 0
- Dividend yield
- 0.00%
- 52-week range
- $0.62 – $8.01
- Volume
- 28.53K
- Avg. volume
- 423.1K
Price performance
ZYBT price history
1M range · 20 trading sessions · Daily adjusted prices
ZYBT closed at $1.38 after 20 trading sessions, down 9.80% for the selected period.
- Last close
- $1.38
- Period change
- -9.80%
- Period low
- $1.38
- Period high
- $2.04
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $1.41 | $1.41 | $1.36 | $1.38 | 28.53K |
| Sep 14, 2026 | $1.55 | $1.55 | $1.40 | $1.42 | 55.32K |
| Sep 11, 2026 | $1.55 | $1.62 | $1.55 | $1.55 | 25.01K |
| Sep 10, 2026 | $1.55 | $1.625 | $1.55 | $1.59 | 45.96K |
| Sep 9, 2026 | $1.56 | $1.64 | $1.56 | $1.57 | 39.53K |
| Sep 8, 2026 | $1.60 | $1.61 | $1.56 | $1.58 | 30.36K |
| Sep 4, 2026 | $1.66 | $1.71 | $1.60 | $1.61 | 34.13K |
| Sep 3, 2026 | $1.65 | $1.68 | $1.5701 | $1.63 | 24.69K |
| Sep 2, 2026 | $1.57 | $1.68 | $1.57 | $1.63 | 54.64K |
| Sep 1, 2026 | $1.74 | $1.79 | $1.63 | $1.65 | 38.95K |
| Aug 31, 2026 | $1.70 | $1.78 | $1.70 | $1.73 | 31.01K |
| Aug 28, 2026 | $1.81 | $1.81 | $1.66 | $1.73 | 37.43K |
| Aug 27, 2026 | $1.80 | $1.8411 | $1.75 | $1.76 | 46.33K |
| Aug 26, 2026 | $1.85 | $1.90 | $1.82 | $1.83 | 34.25K |
| Aug 25, 2026 | $1.91 | $2.01 | $1.86 | $1.89 | 42.85K |
| Aug 24, 2026 | $2.00 | $2.11 | $1.85 | $1.95 | 147.44K |
| Aug 21, 2026 | $1.85 | $2.20 | $1.85 | $2.04 | 279.16K |
| Aug 20, 2026 | $1.81 | $1.95 | $1.77 | $1.89 | 200.26K |
| Aug 19, 2026 | $1.57 | $2.1553 | $1.54 | $1.85 | 1.66M |
| Aug 18, 2026 | $1.52 | $1.6294 | $1.50 | $1.53 | 130.1K |
Latest ZYBT news
The latest Smart Investors Daily articles mentioning ZYBT.
Stock researchCompany · Overview
ZYBT research
Overview
Company profile and research snapshot.
Company profile
Zhengye Biotechnology Holding Ltd is engaged in research, development, manufacturing, and sales of veterinary vaccines, with an emphasis on vaccines for livestock. It has a diverse range of vaccines, including vaccines for swine, cattle, goats, waterfowl, sheep, poultry, and pets, available in various provincial regions across China and are exported overseas to Vietnam, Pakistan, and Egypt. The company generates maximum revenue from the sale of swine vaccines, followed by poultry, and other vaccines.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
Data unavailable
Market data is busy. Please try again shortly.
AI research layers
Interpretive context generated from the platform’s current data sources.
Data unavailable
Market data is busy. Please try again shortly.
